Nature profiles College of Medicine neuroscience doctoral student Christin Godale
Christin Godale, a doctoral student in the Neuroscience Graduate Program, was recently featured in an article in Nature highlighting her advocacy work for neuroscience funding.
Godale was diagnosed at age 2 with epilepsy, which led to her interest in neuroscience. She works with the Society for Neuroscience and has met with federal policymakers and elected officials to increase funding for research.
“Like many people with epilepsy, I rely on anti-seizure medications, which allow me to pursue my dreams and ambitions. Advocating for basic science is very personal for the epilepsy community and myself. Researchers should consider the voices of patient advocates when performing basic research, writing a grant application or giving a scientific presentation,” she says in the article.
Godale works in the laboratory of Steve Danzer, PhD, associate professor in the Department of Anesthesiology, at Cincinnati Children’s.
Last year Godale was selected as an award recipient of the National Institutes of Health (NIH) Outstanding Scholars in Neuroscience Award Program, which recognizes early-career scientists who are conducting exceptional research and who have great academic potential in their scientific training. She also has received an NIH Predoctoral Fellowship from the National Institute of Neurological Disorders and a Predoctoral Fellowship from the American Epilepsy Society.
UC College of Medicine graduate student Christin Godale. (Photo courtesy of Cincinnati Children's)
Featured image at top: Christin Godale/Colleen Kelley/UC Creative + Brand.
Tags
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Breakthrough skin science discovery
March 12, 2026
A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.